C. Deutrich

Determination of a positive malignant hyperthermia (MH) disposition without the in vitro contracture test in families carrying the RYR1 Arg614Cys mutation

D. Olthoff, U. Froster, H. Rueffert, 2001, Clinical genetics.

A new mutation in the skeletal ryanodine receptor gene (RYR1) is potentially causative of malignant hyperthermia, central core disease, and severe skeletal malformation

D. Olthoff, R. Schober, U. Froster, 2004, American journal of medical genetics. Part A.

Spontaneous occurrence of the disposition to malignant hyperthermia.

D. Olthoff, H. Rueffert, C. Deutrich, 2004, Anesthesiology.

A Bifurcated Tracheal Tube for a Neonate with Tracheoesophageal Fistula

D. Olthoff, H. Rueffert, C. Deutrich, 2004 .

Mutation screening in the ryanodine receptor 1 gene (RYR1) in patients susceptible to malignant hyperthermia who show definite IVCT results: identification of three novel mutations

D. Olthoff, U. Froster, H. Rueffert, 2002, Acta anaesthesiologica Scandinavica.

Homozygous and heterozygous Arg614Cys mutations (1840C-->T) in the ryanodine receptor gene co-segregate with malignant hyperthermia susceptibility in a German family.

B. Thamm, D. Olthoff, U. Froster, 2001, British journal of anaesthesia.

[In vitro contracture test and gene typing in diagnosing malignant hyperthermia. Each as an appropriate complement to the other method].

B. Thamm, D. Olthoff, U. Froster, 2000, Der Anaesthesist.

[Regional distribution of predisposition to maligant hyperthermia in Germany: tate in 1997].

J. Scholz, F. Lehmann-Horn, D. Olthoff, 1998, Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS.

Identification of a novel mutation in the ryanodine receptor gene (RYR1) in patients with malignant hyperthermia

D. Olthoff, U. Froster, H. Rueffert, 2001, Human mutation.